Clinical Trials Directory

Trials / Completed

CompletedNCT00997074

Efficacy Study of Prophylactic Ibuprofen Versus Placebo on Pain Relief and Success Rates of Medical Abortion

The Effect of Prophylactic Ibuprofen Versus Placebo on Pain Relief and Success Rates of Medical Abortion: A Double-blind Randomized Placebo Controlled Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
61 (actual)
Sponsor
Sheba Medical Center · Other Government
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

In the current study, we want to evaluate the prophylactic use of ibuprofen versus a placebo for medical abortion by mifepristone and misoprostol, at a gestational age of up to 7 weeks, in regard to the effect on pain relief and the overall procedure success. expected results: The prophylactic use of NSAIDs could offer significant pain relief and thereby a reduction in the need for additional pain relievers compared to the placebo, without interfering with the outcome of medical abortion

Conditions

Interventions

TypeNameDescription
DRUGibuprofenThe most common side effect observed during medical abortion using mifepristone together with misoprostol is abdominal pain. The use of ibuprofen was not shown to interfere with the action of misoprostol to induce uterine contractions and pregnancy expulsion.

Timeline

Start date
2009-10-01
Primary completion
2010-10-01
Completion
2010-10-01
First posted
2009-10-16
Last updated
2012-02-17

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00997074. Inclusion in this directory is not an endorsement.